位置:首页 > 蛋白库 > GSTM2_HUMAN
GSTM2_HUMAN
ID   GSTM2_HUMAN             Reviewed;         218 AA.
AC   P28161; B4DRY4; E9PEM9; Q2M318; Q5TZY5; Q8WWE1;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 210.
DE   RecName: Full=Glutathione S-transferase Mu 2 {ECO:0000305};
DE            EC=2.5.1.18 {ECO:0000269|PubMed:16549767};
DE   AltName: Full=GST class-mu 2;
DE   AltName: Full=GSTM2-2;
GN   Name=GSTM2 {ECO:0000312|HGNC:HGNC:4634}; Synonyms=GST4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=2034681; DOI=10.1073/pnas.88.10.4443;
RA   Vorachek W.R., Pearson W.R., Rule G.S.;
RT   "Cloning, expression, and characterization of a class-mu glutathione
RT   transferase from human muscle, the product of the GST4 locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4443-4447(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF N-TERMINUS.
RC   TISSUE=Testis;
RX   PubMed=8373352; DOI=10.1042/bj2940373;
RA   Ross V.L., Board P.G.;
RT   "Molecular cloning and heterologous expression of an alternatively spliced
RT   human Mu class glutathione S-transferase transcript.";
RL   Biochem. J. 294:373-380(1993).
RN   [7]
RP   PROTEIN SEQUENCE OF 53-69 AND 153-182, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21046276; DOI=10.1007/s11745-010-3485-1;
RA   Brunnstroem A., Hamberg M., Griffiths W.J., Mannervik B., Claesson H.E.;
RT   "Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and
RT   eosinophils.";
RL   Lipids 46:69-79(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE, AND
RP   SUBUNIT.
RX   PubMed=8182750; DOI=10.1006/jmbi.1994.1336;
RA   Raghunathan S., Chandross R.J., Kretsinger R.H., Allison T.J.,
RA   Penington C.J., Rule G.S.;
RT   "Crystal structure of human class mu glutathione transferase GSTM2-2.
RT   Effects of lattice packing on conformational heterogeneity.";
RL   J. Mol. Biol. 238:815-832(1994).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE ANALOG,
RP   FUNCTION, MUTAGENESIS OF THR-210, AND CATALYTIC ACTIVITY.
RX   PubMed=16549767; DOI=10.1073/pnas.0600849103;
RA   Norrgard M.A., Ivarsson Y., Tars K., Mannervik B.;
RT   "Alternative mutations of a positively selected residue elicit gain or loss
RT   of functionalities in enzyme evolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:4876-4881(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE AND
RP   NBDHEX.
RX   PubMed=19808963; DOI=10.1158/0008-5472.can-09-1314;
RA   Federici L., Lo Sterzo C., Pezzola S., Di Matteo A., Scaloni F.,
RA   Federici G., Caccuri A.M.;
RT   "Structural basis for the binding of the anticancer compound 6-(7-nitro-
RT   2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.";
RL   Cancer Res. 69:8025-8034(2009).
CC   -!- FUNCTION: Conjugation of reduced glutathione to a wide number of
CC       exogenous and endogenous hydrophobic electrophiles. Participates in the
CC       formation of novel hepoxilin regioisomers (PubMed:21046276).
CC       {ECO:0000269|PubMed:16549767, ECO:0000269|PubMed:21046276}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutathione + RX = a halide anion + an S-substituted
CC         glutathione + H(+); Xref=Rhea:RHEA:16437, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16042, ChEBI:CHEBI:17792, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:90779; EC=2.5.1.18;
CC         Evidence={ECO:0000269|PubMed:16549767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16438;
CC         Evidence={ECO:0000305|PubMed:16549767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11(S)-hydroxy-14(S),15(S)-epoxy-(5Z,8Z,12E)-eicosatrienoate +
CC         glutathione = (11S,15S)-dihydroxy-14(R)-S-glutathionyl-(5Z,8Z,12E)-
CC         eicosatrienoate; Xref=Rhea:RHEA:50260, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:132200, ChEBI:CHEBI:132201;
CC         Evidence={ECO:0000269|PubMed:21046276};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50261;
CC         Evidence={ECO:0000305|PubMed:21046276};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16549767,
CC       ECO:0000269|PubMed:19808963, ECO:0000269|PubMed:8182750}.
CC   -!- INTERACTION:
CC       P28161; P46439: GSTM5; NbExp=6; IntAct=EBI-9023362, EBI-4312072;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28161-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28161-2; Sequence=VSP_045614;
CC   -!- TISSUE SPECIFICITY: Muscle.
CC   -!- SIMILARITY: Belongs to the GST superfamily. Mu family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M63509; AAA60963.1; -; mRNA.
DR   EMBL; AK299482; BAG61446.1; -; mRNA.
DR   EMBL; BT019947; AAV38750.1; -; mRNA.
DR   EMBL; AC000031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000032; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC105038; AAI05039.1; -; mRNA.
DR   EMBL; BC105066; AAI05067.1; -; mRNA.
DR   CCDS; CCDS44192.1; -. [P28161-2]
DR   CCDS; CCDS808.1; -. [P28161-1]
DR   PIR; A39375; A39375.
DR   RefSeq; NP_000839.1; NM_000848.3. [P28161-1]
DR   RefSeq; NP_001135840.1; NM_001142368.1. [P28161-2]
DR   PDB; 1HNA; X-ray; 1.85 A; A=2-218.
DR   PDB; 1HNB; X-ray; 3.50 A; A/B=2-218.
DR   PDB; 1HNC; X-ray; 3.00 A; A/B/C/D=2-218.
DR   PDB; 1XW5; X-ray; 1.80 A; A/B=2-218.
DR   PDB; 1YKC; X-ray; 2.10 A; A/B=2-218.
DR   PDB; 2AB6; X-ray; 2.50 A; A/B/C/D=2-218.
DR   PDB; 2C4J; X-ray; 1.35 A; A/B/C/D=2-218.
DR   PDB; 2GTU; X-ray; 2.55 A; A/B=2-218.
DR   PDB; 3GTU; X-ray; 2.80 A; A/C=2-218.
DR   PDB; 3GUR; X-ray; 2.50 A; A/B/C/D=2-218.
DR   PDB; 5HWL; X-ray; 1.60 A; A/B=2-218.
DR   PDBsum; 1HNA; -.
DR   PDBsum; 1HNB; -.
DR   PDBsum; 1HNC; -.
DR   PDBsum; 1XW5; -.
DR   PDBsum; 1YKC; -.
DR   PDBsum; 2AB6; -.
DR   PDBsum; 2C4J; -.
DR   PDBsum; 2GTU; -.
DR   PDBsum; 3GTU; -.
DR   PDBsum; 3GUR; -.
DR   PDBsum; 5HWL; -.
DR   AlphaFoldDB; P28161; -.
DR   BMRB; P28161; -.
DR   SMR; P28161; -.
DR   BioGRID; 109201; 12.
DR   IntAct; P28161; 4.
DR   STRING; 9606.ENSP00000241337; -.
DR   BindingDB; P28161; -.
DR   ChEMBL; CHEMBL4589; -.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB03310; Glutathione disulfide.
DR   DrugBank; DB02458; S-(2,4-dinitrophenyl)glutathione.
DR   DrugBank; DB04701; S-Methyl glutathione.
DR   SwissLipids; SLP:000001614; -.
DR   GlyGen; P28161; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P28161; -.
DR   PhosphoSitePlus; P28161; -.
DR   BioMuta; GSTM2; -.
DR   DMDM; 232204; -.
DR   OGP; P28161; -.
DR   REPRODUCTION-2DPAGE; P28161; -.
DR   EPD; P28161; -.
DR   jPOST; P28161; -.
DR   MassIVE; P28161; -.
DR   MaxQB; P28161; -.
DR   PaxDb; P28161; -.
DR   PeptideAtlas; P28161; -.
DR   PRIDE; P28161; -.
DR   ProteomicsDB; 19925; -.
DR   ProteomicsDB; 54450; -. [P28161-1]
DR   Antibodypedia; 20072; 247 antibodies from 31 providers.
DR   CPTC; P28161; 3 antibodies.
DR   DNASU; 2946; -.
DR   Ensembl; ENST00000241337.9; ENSP00000241337.4; ENSG00000213366.13. [P28161-1]
DR   Ensembl; ENST00000442650.5; ENSP00000416883.1; ENSG00000213366.13. [P28161-2]
DR   Ensembl; ENST00000460717.7; ENSP00000435910.2; ENSG00000213366.13. [P28161-2]
DR   GeneID; 2946; -.
DR   KEGG; hsa:2946; -.
DR   MANE-Select; ENST00000241337.9; ENSP00000241337.4; NM_000848.4; NP_000839.1.
DR   UCSC; uc001dyj.4; human. [P28161-1]
DR   CTD; 2946; -.
DR   DisGeNET; 2946; -.
DR   GeneCards; GSTM2; -.
DR   HGNC; HGNC:4634; GSTM2.
DR   HPA; ENSG00000213366; Low tissue specificity.
DR   MIM; 138380; gene.
DR   neXtProt; NX_P28161; -.
DR   OpenTargets; ENSG00000213366; -.
DR   PharmGKB; PA29023; -.
DR   VEuPathDB; HostDB:ENSG00000213366; -.
DR   eggNOG; KOG1695; Eukaryota.
DR   GeneTree; ENSGT00940000155416; -.
DR   InParanoid; P28161; -.
DR   OMA; NRLPEMM; -.
DR   PhylomeDB; P28161; -.
DR   TreeFam; TF353040; -.
DR   BRENDA; 2.5.1.18; 2681.
DR   PathwayCommons; P28161; -.
DR   Reactome; R-HSA-156590; Glutathione conjugation.
DR   SABIO-RK; P28161; -.
DR   SignaLink; P28161; -.
DR   BioGRID-ORCS; 2946; 12 hits in 1078 CRISPR screens.
DR   ChiTaRS; GSTM2; human.
DR   EvolutionaryTrace; P28161; -.
DR   GeneWiki; GSTM2; -.
DR   GenomeRNAi; 2946; -.
DR   Pharos; P28161; Tchem.
DR   PRO; PR:P28161; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P28161; protein.
DR   Bgee; ENSG00000213366; Expressed in left ovary and 94 other tissues.
DR   ExpressionAtlas; P28161; baseline and differential.
DR   Genevisible; P28161; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0005504; F:fatty acid binding; IPI:BHF-UCL.
DR   GO; GO:0043295; F:glutathione binding; IDA:BHF-UCL.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL.
DR   GO; GO:0004364; F:glutathione transferase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0070458; P:cellular detoxification of nitrogen compound; IDA:BHF-UCL.
DR   GO; GO:0071313; P:cellular response to caffeine; IDA:BHF-UCL.
DR   GO; GO:0006749; P:glutathione metabolic process; IDA:UniProtKB.
DR   GO; GO:0051122; P:hepoxilin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0018916; P:nitrobenzene metabolic process; IDA:BHF-UCL.
DR   GO; GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; IC:BHF-UCL.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL.
DR   GO; GO:0042178; P:xenobiotic catabolic process; IDA:UniProtKB.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR040079; Glutathione_S-Trfase.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR004046; GST_C.
DR   InterPro; IPR003081; GST_mu.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   Pfam; PF14497; GST_C_3; 1.
DR   Pfam; PF02798; GST_N; 1.
DR   PRINTS; PR01267; GSTRNSFRASEM.
DR   SFLD; SFLDS00019; Glutathione_Transferase_(cytos; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS50404; GST_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Lipid metabolism; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..218
FT                   /note="Glutathione S-transferase Mu 2"
FT                   /id="PRO_0000185818"
FT   DOMAIN          2..88
FT                   /note="GST N-terminal"
FT   DOMAIN          90..208
FT                   /note="GST C-terminal"
FT   BINDING         7..8
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:16549767,
FT                   ECO:0000269|PubMed:19808963"
FT   BINDING         43..46
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:16549767,
FT                   ECO:0000269|PubMed:19808963"
FT   BINDING         50
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000250|UniProtKB:P08010"
FT   BINDING         59..60
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:16549767,
FT                   ECO:0000269|PubMed:19808963"
FT   BINDING         72..73
FT                   /ligand="glutathione"
FT                   /ligand_id="ChEBI:CHEBI:57925"
FT                   /evidence="ECO:0000269|PubMed:16549767,
FT                   ECO:0000269|PubMed:19808963"
FT   BINDING         116
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            210
FT                   /note="Important for substrate specificity"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08010"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08010"
FT   VAR_SEQ         190..218
FT                   /note="GLEKISAYMKSSRFLPRPVFTKMAVWGNK -> HS (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045614"
FT   VARIANT         173
FT                   /note="S -> N (in dbSNP:rs2229050)"
FT                   /id="VAR_049486"
FT   MUTAGEN         210
FT                   /note="T->C,F,H,I,K,L,R,Y,W: Reduced enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:16549767"
FT   CONFLICT        2
FT                   /note="P -> S (in Ref. 3; AAV38750)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        9
FT                   /note="N -> D (in Ref. 3; AAV38750)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        51
FT                   /note="F -> L (in Ref. 2; BAG61446)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..11
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           12..14
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           15..23
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   TURN            38..41
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           44..47
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   TURN            48..51
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   STRAND          68..72
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           73..83
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           91..116
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           120..142
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           155..170
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   TURN            172..177
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           179..190
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   HELIX           192..199
FT                   /evidence="ECO:0007829|PDB:2C4J"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:1XW5"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:1HNC"
FT   TURN            208..212
FT                   /evidence="ECO:0007829|PDB:1HNA"
FT   STRAND          214..216
FT                   /evidence="ECO:0007829|PDB:2C4J"
SQ   SEQUENCE   218 AA;  25745 MW;  15203709D4A63789 CRC64;
     MPMTLGYWNI RGLAHSIRLL LEYTDSSYEE KKYTMGDAPD YDRSQWLNEK FKLGLDFPNL
     PYLIDGTHKI TQSNAILRYI ARKHNLCGES EKEQIREDIL ENQFMDSRMQ LAKLCYDPDF
     EKLKPEYLQA LPEMLKLYSQ FLGKQPWFLG DKITFVDFIA YDVLERNQVF EPSCLDAFPN
     LKDFISRFEG LEKISAYMKS SRFLPRPVFT KMAVWGNK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024